<DOC>
	<DOC>NCT02869750</DOC>
	<brief_summary>To evaluate possible clinical effects of adipokines , ( ghrelin, resistin and adiponectin), in obese and non-obese patients with polycystic ovary syndrome (PCOS).</brief_summary>
	<brief_title>Evaluation of Adipokines in Obese and Non-obese Egyptian Women With Polycystic Ovary Syndrome</brief_title>
	<detailed_description>Seventy selected PCOS patients will be recruited for this study, and will be divided into two groups based on their body mass index (BMI): 35 obese (BMIâ‰¥ 25 kg/m2, group A), 35 non-obese (BMI&lt;25 kg/m2, group B). In addition, 35 healthy non-obese women (BMI&lt;25 kg/m2) will bw enrolled as the control (group C). Serum levels of FSH (follicle stimulating hormone), LH (luteinizing hormone), T(testosterone), glucose, insulin, adiponectin, resistin and resistin will bw detected, and compared the differences of them among three groups</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<criteria>Females with PCOS in child bearing age who presented at reproductive and endocrinology clinics at Ain Shams University Maternity Hospital Known androgen secreting tumor. PCO on ovarian stimulation medications PCO with any other medical illness.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>